blood pressure may decrease alongside weight loss, and any cardiovascular effects should be interpreted in the context of overall trial data rather than assumed to be adverse
Obesity can lead to several health problems, including heart disease, stroke, type 2 diabetes, and certain types of cancer
If you want more detail on whether GLP-1s belong in the refrigerator, does GLP-1 have to be refrigerated
As previously noted, even the lowest effective 4mg aw dose provided compelling health benefits It will be compelling to see how triple-agonist therapy is tolerated in the long term especially given that single and dual incretin-based therapies show substantial discontinuation rates in real-world settings, in some cohorts approaching 70%
Emerging role of GLP-1 agonists in obesity: a comprehensive review of randomised controlled trials
Exposure to temperatures above recommended levels can decrease its effectiveness